Ömer Faruk Karataş,
Fatma Şanlı,
Neslişah Barlak,
Ahsen Kılınç,
Özel Çapık,
Abdülmelik Aytatlı
The AKT antagonist AZD5363 suppresses features associated with cancer progression in human larynx cancer cells
The AKT antagonist AZD5363 suppresses features associated with cancer progression in human larynx cancer cells
The European Research Journal
2020-Cilt: 6 - Sayı: 5
380-387
54
75